The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients
Recruiting
N/A
Interventional Study
Critical Illness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 315 (estimated)
- Sponsor
- Hospital Civil de Guadalajara · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Most recent guidelines suggest central venous access must be performed with real-time ultrasound guidance, and the most recommended site for cannulation is internal jugular vein (IJV); however, it is recognized that evidence for other sites is, at present, limited. Besides, guidelines does not account for patients with small vein cross-sectional area and/or respirophasic collapse, which can make t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who need central venous catheterization, and have respirophasic variation in cross-sectional area of jugular veins
Exclusion Criteria:
* Less than 18 years-old
* Patients with previous failed attempts with non-ultrasound guided technique
* Non-resolved pneumoth…
Contacts
Guadalupe Aguirre-Avalos, MD
CONTACT